If you need more lookups,
subscriptions start at $34 USD/month.
Jack Huang Location
United States
Jack Huang Work
Vice President and Head of Drug Safety and Pharmacovigilance @ (July 2021 - Present)
Principal Medical Director and Safety Strategy Leader, Early Clinical Development Oncology @ (August 2019 - July 2021)
VP, Head of Drug Safety @ (August 2017 - July 2019)
Sr. Safety Science Leader, Early Clinical Development Oncology @ (September 2010 - August 2017)
Medical Director, Global Pharmacovigilance and Epidemiology (Oncology Therapeutic Area) @ (April 2007 - September 2010)
Senior Director, Pharmacovigilance @ (September 2006 - April 2007)
Medical Director, Global Pharmacovigilance and Labeling @ (December 2002 - September 2006)
Senior Clinical Safety Officer @ (May 2000 - December 2002)
Head of Drug Safety, Product Development and Post-Marketing @ (February 1997 - May 2000)
Specialist @ (April 1995 - February 1997)
Postdoctoral Fellow, Toxicology and Pharmacology @ (April 1993 - March 1995)
Jack Huang Education
Nagoya University
(Medicine)
Peking University Health Science Center
Doctor Of Medicine (Medicine)
Jack Huang Skills
Occupational Medicine
Clinical Trials
Translational Medicine
CRO
Epidemiology
Clinical Research
Biotechnology
Life Sciences
Pharmacoepidemiology
Pharmacovigilance
Environmental Toxicology
Oncology Clinical Research
Medicine
Oncology
GCP
Drug Development
Clinical Development
Pharmacology
Drug Safety
Pharmaceutical Industry
Medical Affairs
Jack Huang Summary
Jack Huang, based in United States, is currently a Vice President and Head of Drug Safety and Pharmacovigilance at Arrivent Biopharma. Jack Huang brings experience from previous roles at Genentech, Nektar Therapeutics and Bristol-Myers Squibb. Jack Huang holds a Nagoya University. With a robust skill set that includes Occupational Medicine, Clinical Trials, Translational Medicine, CRO, Epidemiology and more. Jack Huang has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Jack Huang?
Find contact details for 700 million professionals.